MARWAN MOUGHRABI: Open Payments
NPI 1699722421 · HIXSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,706 in 129 payments from 25 companies in 2025. Trend: 2023 $2,863 · 2024 $2,694 · 2025 $2,706
Food & beverage: $2,661Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $444 |
| AstraZeneca Pharmaceuticals LP | 12 | $356 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $252 |
| Otsuka America Pharmaceutical, Inc. | 10 | $184 |
| ABBVIE INC. | 12 | $181 |
| Eisai Inc. | 3 | $167 |
| Vanda Pharmaceuticals Inc. | 12 | $141 |
| PFIZER INC. | 8 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $117 |
| Lilly USA, LLC | 4 | $96 |
Products named: REXULTI, Kerendia, AIRSUPRA, Leqembi, Ozempic, Rybelsus, FANAPT, Wegovy.
Industry payments across TN — which companies pay providers there.
